<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04761354</url>
  </required_header>
  <id_info>
    <org_study_id>16-196/C</org_study_id>
    <nct_id>NCT04761354</nct_id>
  </id_info>
  <brief_title>Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis</brief_title>
  <official_title>Characteristics Predicting Clinically Relevant Reduction of Hypertension Following Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northwestern Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Montreal General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Sydney</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>UMC Utrecht</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary aldosteronism (PA) is the excessive endogenous production of the mineralocorticoid&#xD;
      aldosterone. Although various rare forms of PA exist, the vast majority of cases are&#xD;
      accounted by either an aldosterone-producing adenoma (APA) or bilateral adrenal hyperplasia.&#xD;
      During the last decades the prevalence of PA has risen, predominantly due to better awareness&#xD;
      of disease. Several studies estimated a prevalence of PA up to 17% in an unselected&#xD;
      population of hypertensive patients. However, in a population with resistant hypertension the&#xD;
      reported prevalence is even higher: 17-23%. This emphasizes the clinical impact of PA on&#xD;
      morbidity and mortality due to high blood pressure. Since both hypertension and aldosteronism&#xD;
      are independent risk factors for cardiovascular morbidity, the aim of treatment is curation&#xD;
      or reduction of both.&#xD;
&#xD;
      After an adrenalectomy for APA normalization of biochemical abnormalities is achieved in&#xD;
      almost all cases. Nevertheless, curation of hypertension (systolic blood pressure &lt;140 and&#xD;
      diastolic blood pressure &lt;90 mmHg) without the need of antihypertensive medication is&#xD;
      accomplished in only 35-45% of the cases. In 2008 the Aldosteronoma Resolution Score (ARS)&#xD;
      was developed. This score predicts the likelihood of complete resolution of the hypertension&#xD;
      in patients with an aldosteronoma and has been validated by other investigator groups.&#xD;
&#xD;
      Reduction of hypertension is also an important clinical outcome and is reported in 90-98% of&#xD;
      the patients after surgery. In most studies reduction is defined as a certain decrease in&#xD;
      blood pressure or antihypertensive medication. However, there is no consensus on the precise&#xD;
      definition of reduction in these patients, which leads to incomparable results.&#xD;
&#xD;
      The aim of the proposed study is to determine the proportion of patients with clinically&#xD;
      relevant reduction of hypertension after adrenalectomy in a large cohort. Furthermore, the&#xD;
      investigators aim to determine the characteristics predicting this clinically relevant&#xD;
      reduction. Additionally, the investigators evaluate the predictive value of the Aldosteronoma&#xD;
      Resolution Score for clinically relevant reduction and aim to develop a scoring system to&#xD;
      help clinicians predict the likelihood of reduction of hypertension after adrenalectomy so it&#xD;
      can be used for patient counseling.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 26, 2016</start_date>
  <completion_date type="Actual">March 26, 2017</completion_date>
  <primary_completion_date type="Actual">March 26, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative blood pressure measurement</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>systolic and diastolic blood pressure via office blood pressure measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>antihypertensive medication use</measure>
    <time_frame>6 months postoperative (corresponding to the entered postoperative blood pressure)</time_frame>
    <description>number of antihypertensives in defined daily dose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>resolution of hypertension</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>resolution of hypertension score via the PASO consensus criteria</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative serum potassium level</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>Serum potassium in mmol/l.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative plasma aldosterone level in lying and standing position</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>Plasma aldosterone in nmol/l.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative plasma renin activity in lying and standing position</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>Plasma renin activity in mg/L/u.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative aldosterone to renin ratio</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>Aldosterone to renin ratio using plasma aldosterone level and plasma renin activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative plasma creatinine level</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>Plasma creatinine in mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pathology</measure>
    <time_frame>6 months postoperative</time_frame>
    <description>Final result of pathology after adrenalectomy</description>
  </secondary_outcome>
  <number_of_groups>16</number_of_groups>
  <enrollment type="Actual">514</enrollment>
  <condition>Primary Aldosteronism Due to Aldosterone Producing Adenoma</condition>
  <condition>Primary Aldosteronism</condition>
  <condition>Primary Aldosteronism Due to Conn Adenoma</condition>
  <arm_group>
    <arm_group_label>University Medical Center Utrecht</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>University Medical Center Groningen</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vu University Medical Center Amsterdam</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>University Medical Center Maastricht</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Academic Medical Center Amsterdam</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Istituto di Semeiotica Chirurgica Roma</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>University of California San Francisco</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Northwestern Memorial Hospital</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Weill Cornell Medical Center</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Columbia University Medical Center</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>University of Chicago Medical Center</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>M.D. Anderson Cancer Center</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Boston Medical Center</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>University Health Network Toronto</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Montreal General Hospital - McGill University</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>University of Sydney</arm_group_label>
    <description>Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Unilateral adrenalectomy</intervention_name>
    <arm_group_label>Academic Medical Center Amsterdam</arm_group_label>
    <arm_group_label>Boston Medical Center</arm_group_label>
    <arm_group_label>Columbia University Medical Center</arm_group_label>
    <arm_group_label>Istituto di Semeiotica Chirurgica Roma</arm_group_label>
    <arm_group_label>M.D. Anderson Cancer Center</arm_group_label>
    <arm_group_label>Montreal General Hospital - McGill University</arm_group_label>
    <arm_group_label>Northwestern Memorial Hospital</arm_group_label>
    <arm_group_label>University Health Network Toronto</arm_group_label>
    <arm_group_label>University Medical Center Groningen</arm_group_label>
    <arm_group_label>University Medical Center Maastricht</arm_group_label>
    <arm_group_label>University Medical Center Utrecht</arm_group_label>
    <arm_group_label>University of California San Francisco</arm_group_label>
    <arm_group_label>University of Chicago Medical Center</arm_group_label>
    <arm_group_label>University of Sydney</arm_group_label>
    <arm_group_label>Vu University Medical Center Amsterdam</arm_group_label>
    <arm_group_label>Weill Cornell Medical Center</arm_group_label>
    <other_name>Endoscopic posterior adrenalectomy</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary aldosteronism patients who underwent unilateral adrenalectomy between 2010 and 2016&#xD;
        for APA&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients who underwent unilateral adrenalectomy between 2010 and 2016 for APA.&#xD;
&#xD;
          -  Patients with biochemical evidence of primary aldosteronism who underwent&#xD;
             adrenalectomy on account of an aldosterone-producing adenoma(APA), proven by&#xD;
             Computerized Tomography(CT) or Magnetic Resonance Imaging(MRI) or Adrenal Venous&#xD;
             Sampling(AVS).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18 years.&#xD;
&#xD;
          -  Missing or incomplete data about preoperative blood pressure and number of&#xD;
             antihypertensive drugs.&#xD;
&#xD;
          -  Missing or incomplete follow-up data about postoperative blood pressure and number of&#xD;
             antihypertensive drugs. We aim enter the blood pressure and number of antihypertensive&#xD;
             drugs closest to 6 months after adrenalectomy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Menno R Vriens, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerlof D Valk, MD</last_name>
    <role>Study Director</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M.D. Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Sydney</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Health Network Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal General Hospital - McGill University</name>
      <address>
        <city>Montr√©al</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto di Semeiotica Chirurgica Roma</name>
      <address>
        <city>Rome</city>
        <state>Lazio</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amsterdam University Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30.</citation>
    <PMID>28576687</PMID>
  </reference>
  <reference>
    <citation>Zarnegar R, Young WF Jr, Lee J, Sweet MP, Kebebew E, Farley DR, Thompson GB, Grant CS, Clark OH, Duh QY. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg. 2008 Mar;247(3):511-8. doi: 10.1097/SLA.0b013e318165c075.</citation>
    <PMID>18376197</PMID>
  </reference>
  <reference>
    <citation>Utsumi T, Kawamura K, Imamoto T, Kamiya N, Komiya A, Suzuki S, Nagano H, Tanaka T, Nihei N, Naya Y, Suzuki H, Tatsuno I, Ichikawa T. High predictive accuracy of Aldosteronoma Resolution Score in Japanese patients with aldosterone-producing adenoma. Surgery. 2012 Mar;151(3):437-43. doi: 10.1016/j.surg.2011.08.001. Epub 2011 Oct 13.</citation>
    <PMID>22000827</PMID>
  </reference>
  <reference>
    <citation>Aronova A, Gordon BL, Finnerty BM, Zarnegar R, Fahey TJ 3rd. Aldosteronoma resolution score predicts long-term resolution of hypertension. Surgery. 2014 Dec;156(6):1387-92; discussion 1392-3. doi: 10.1016/j.surg.2014.08.019. Epub 2014 Nov 11.</citation>
    <PMID>25456916</PMID>
  </reference>
  <reference>
    <citation>Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens. 2003 Nov;21(11):2149-57.</citation>
    <PMID>14597859</PMID>
  </reference>
  <results_reference>
    <citation>Vorselaars WMCM, Nell S, Postma EL, Zarnegar R, Drake FT, Duh QY, Talutis SD, McAneny DB, McManus C, Lee JA, Grant SB, Grogan RH, Romero Arenas MA, Perrier ND, Peipert BJ, Mongelli MN, Castelino T, Mitmaker EJ, Parente DN, Pasternak JD, Engelsman AF, Sywak M, D'Amato G, Raffaelli M, Schuermans V, Bouvy ND, Eker HH, Bonjer HJ, Vaarzon Morel NM, Nieveen van Dijkum EJM, Vrielink OM, Kruijff S, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR; International CONNsortium study group. Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism. JAMA Surg. 2019 Apr 1;154(4):e185842. doi: 10.1001/jamasurg.2018.5842. Epub 2019 Apr 17.</citation>
    <PMID>30810749</PMID>
  </results_reference>
  <results_reference>
    <citation>Vorselaars WMCM, van Beek DJ, Postma EL, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR; International CONNsortium study group. Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators' consensus criteria within a worldwide cohort of patients. Surgery. 2019 Jul;166(1):61-68. doi: 10.1016/j.surg.2019.01.031. Epub 2019 May 1.</citation>
    <PMID>31053245</PMID>
  </results_reference>
  <results_reference>
    <citation>Vorselaars WMCM, van Beek DJ, Postma EL, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR; International CONNsortium Study Group. Validation of the Aldosteronoma Resolution Score Within Current Clinical Practice. World J Surg. 2019 Oct;43(10):2459-2468. doi: 10.1007/s00268-019-05074-z. Erratum in: World J Surg. 2019 Sep 5;:.</citation>
    <PMID>31270571</PMID>
  </results_reference>
  <results_reference>
    <citation>Vorselaars WMCM, van Beek DJ, Suurd DPD, Postma E, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR; International CONNsortium*. Adrenalectomy for Primary Aldosteronism: Significant Variability in Work-Up Strategies and Low Guideline Adherence in Worldwide Daily Clinical Practice. World J Surg. 2020 Jun;44(6):1905-1915. doi: 10.1007/s00268-020-05408-2.</citation>
    <PMID>32025781</PMID>
  </results_reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 10, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UMC Utrecht</investigator_affiliation>
    <investigator_full_name>Prof. dr. M.R. Vriens</investigator_full_name>
    <investigator_title>Professor in Endocrine and Oncological Surgery</investigator_title>
  </responsible_party>
  <keyword>Primary Aldosteronism</keyword>
  <keyword>Hyperaldosteronism</keyword>
  <keyword>Adrenalectomy</keyword>
  <keyword>Blood Pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Adrenocortical Adenoma</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hyperaldosteronism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 4, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT04761354/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

